RADx Tech accelerates FDA authorization of first point-of-care hepatitis C test

RADx Tech accelerates FDA authorization of first point-of-care hepatitis C test: The NIBIB Director Dr. Bruce Tromberg discusses the latest accomplishment by the RADx Tech Independent Test Assessment Program with the authorization of the first point-of-care hepatitis C virus diagnostic test.